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Background: Leishmaniasis is a zoonotic disease caused by leish-
mania parasites. Cutaneous Leishmaniasis (CL) is still one of
the health problems in tropical areas and Iran. In this study,
paromomycin was applied for the treatment of CL in vivo in
Balb/c mice infected with Leishmania major in order to study its
anti-leishmanial effects, inhibition of visceralization, reduction
of lesion size and proliferation of anastigotes.
Methods: Experimental CL was initiated by injection of pro-
mastigotes into the Balb/c mice followed by a small nodule
which converted to a lesion. The progress of lesion size was mea-
sured weekly. After Paromomycin injection, patho-physiological
manifestations and side effects were assessed frequently. Finally,
all mice were killed by terminal anesthesia and target tissues
were removed, weighted, their impression smears prepared
and stained for detection of amastigotes. The proliferation of
amastigotes was evaluated by counting them inside ﬁve random
macrophages and mean percentages were calculated as degree
of proliferation. Pathological changes in treated mice, presence
of amastigotes in target organs and their proliferation were also
evaluated.
Results: Although, lesion size in control group had an increase
trend, it has reduced in test groups, particularly high concen-
tration showed an anti-leishmanial activity with a signiﬁcant
reduction of lesion size. Both hepatomegaly and splenomegaly
have been decreased in test groups.
Conclusion: The evaluation of anti-leishmanial effects of paro-
momomycin and its inhibition of visceralization was succeeded
in L .major infected Balb/c mice. Therefore, injectable paro-
momycin is introduced as a relevant therapy for the treatment in
rodent model of CL.
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Background: Leishmaniasis is a zoonotic infection caused by
protozoa of the genus Leishmania, which is a major health
problem in developing countries. Clinical forms of disease are
classiﬁed as Visceral (VL), Cutaneous (CL) and mucocutaneous
leishmaniasis (MCL). CL is still one of health problems in Iran
and region. Nitric oxide (NO) eliminates parasite by its anti-
leishmanial activity and prostaglandin (PG) inhibits actions of
infected macrophages.
Methods: In this study, NO is induced by L-Arginine and PG is
inhibited by Indomethacin in L. major infected Balb/c mice, in
order to evaluate the NO/PG effects on proliferation of amastig-
otes, lesion size and its formation. Target organs were studied
to detect amastigotes and to investigate NO induction by Griess
microassay and to determine PG by ELISA.
Results: NO was inhibited by Leishmania itself and by a com-
bination of L-Arginine-Indomethacin as well in infected host.
Although NO was decreased in liver by L-Arginine, it in-
creased in spleen after L-Arginine-Indomethacin. A signiﬁcant
decline was observed in lesion size by Indomethacin. L-Arginine-
Indomethacin had signiﬁcant inhibitory effects on leishmania
visceralisation. L-Arginine alone decreased proliferation of pro-
mastigotes in macrophages. Pathophysiological signs including
hepato/splenomegaly, survival rate and body weight all were
affected in this experiment.
Conclusion: NO and PG modulation are able to alter the patho-
physiological signs in leishmania infected mice and data revealed
an association between NO induction and PG inhibition which
may indicate a possible role for L-Arginine-Indomethacin as novel
therapy in leishmaniasis.
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Background: Malaria is a major problem in many countries and
Iran. Controlling malaria is now becoming difﬁcult because of
the developing resistance of P. falciparum to commonly used
antimalarial drugs. Artemisia is one of major genus of the family
Asteraceae, which is a potent antimalarial drug and could be a
source of treatment. Artemisia is represented by wild species
growing in different parts of Iran and some species are endemic.
Methods: The Iranian ﬂora A. khorasanica was collected at
ﬂowering stage from Ghouchan Mountains in Khorassan province
north-eastern Iran and aerial parts were air-dried in shade.
Its chemical components were identiﬁed by GCMS, extracted
in methanol and subsequently fractionated by bromohexane.
Extraction was applied by air-dry procedure and the residue
separated by column chromatography. Elution column was done
by extract analysis using Thin-layer chromatography. Toxicity
was assessed by inoculation of herbal extract into naive mice
and in vivo anti-malarial effects of A. khorassanica extract was
evaluated against Plasmodium berghei infection.
Results: This study demonstrated A. khorassaniaca possess anti-
malarial activity and results were supported by Spectrometry of
products and identiﬁcation of chemical non-polar components by
GCMS.
Conclusion: The antimalarial action of A. khorasanica was ob-
served against P. berghei and can be attributed to the presence
of its compounds as an antiplasmodial drug. This study revealed
that A. khorassanica had high amounts of sesquiterpene lactones,
but it needs more studies to be clariﬁed. This is the ﬁrst appli-
cation of this herbal extract and its composition against murine
malaria infection.
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Objectives: Cystic echinococcosis caused by Echinococcus spp. is
considered hyper endemic in Iran. To clarify the present status of
hydatidosis in Iran the present review article is presented.
Methods: Authentic databases and search engines from 1996
onwards were utilized to enquire the situation of the disease in
Iran.
Results: Human hydatidosis is responsible for approximately 1%
of admission to surgical wards and the rate of human infection is
0.6-1.2/100000. The usual order of involvement, i.e. liver, lung,
and other organs, respectively is documented here as well. Risk
factors include contact with dog, eating vegetable, geophagy
